NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tronox Holdings plc ("Tronox" or "the Company") (NYSE:TROX). Investors who purchased Tronox securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/TROX. Investigation […]

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Albany International Corp. ("Albany" or "the Company") (NYSE:AIN). Investors who purchased Albany securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AIN.

NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of agilon health, inc. ("Agilon" or "the Company") (NYSE:AGL). Investors who purchased Agilon securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AGL. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fluor Corporation ("Fluor" or "the Company") (NYSE:FLR). Investors who purchased Fluor securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FLR. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 15, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lineage, Inc. ("Lineage" or "the Company") (NASDAQ:LINE) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Exelixis, Inc. ("Exelixis" or "the Company") (NASDAQ:EXEL). Investors who purchased Exelixis securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EXEL. Investigation Details

NEW YORK, NY / ACCESS Newswire / August 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortinet, Inc. ("Fortinet" or "the Company") (NASDAQ:FTNT). Investors who purchased Fortinet securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FTNT. Investigation Details

“I wanted to create a fun and effective piano learning tool for the various elements of music theory,” said an inventor, from Billings,Mont., “so I invented the P. I. A. My design would provide a clear visual indication of the scale degrees, scales, intervals, and chords in different major and minor keys, and it would

The global Epigenetics Market, valued at US$2.03 billion in 2024, stood at US$2.24 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of US$4.29 billion by the end of the period. The major factors driving the growth in the flow cytometry

Monport will officially launch AutoForge, the world's first laser engraver with an automatic loading system, on Kickstarter on August 19, 2025, at 9:00 AM EDT. This breakthrough machine combines dual-laser versatility, MOPA fiber laser color marking, and UV crystal engraving with a large 230×230 mm workspace – delivering unmatched speed, precision, and hands-free productivity for